1-vinylpyrene

CAS No. 17088-21-0

1-vinylpyrene( —— )

Catalog No. M36921 CAS No. 17088-21-0

1-vinylpyrene (1-Ethenylpyrene) has antitumor activity and strongly inhibits the formation of skin tumors triggered by DMBA or B[]P in a dose-dependent manner and can be used to prevent tumor formation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 53 In Stock
25MG 90 In Stock
50MG 140 In Stock
100MG 205 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-vinylpyrene
  • Note
    Research use only, not for human use.
  • Brief Description
    1-vinylpyrene (1-Ethenylpyrene) has antitumor activity and strongly inhibits the formation of skin tumors triggered by DMBA or B[]P in a dose-dependent manner and can be used to prevent tumor formation.
  • Description
    1-vinylpyrene (1-Ethenylpyrene) has antitumor activity and strongly inhibits the formation of skin tumors triggered by DMBA or B[]P in a dose-dependent manner and can be used to prevent tumor formation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17088-21-0
  • Formula Weight
    228.29
  • Molecular Formula
    C18H12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C)C1=C2C3=C4C(C=C2)=CC=CC4=CC=C3C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Linzagolix

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.

  • Calycosin

    Calycosin (Cyclosin) is a natural active compound with anti-oxidative and anti-inflammation activity.

  • YK-2-69

    YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.